NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
Sign in Subscribe

Mesoblast Gets FDA Nod for Extra Quality Check on Ryoncil

Mesoblast received FDA approval for a new TIBA assay to check strength and stability of every commercial Ryoncil batch as manufacturing scales.

Mesoblast Gets FDA Nod for Extra Quality Check on Ryoncil
Credit: Mesoblast
Already have an account? Sign in.
09/24/2026 · 7:41 AM
MESO
/ Don’t stop at just one post.

Related↓

Mesoblast’s Potential Blockbuster Back Pain Therapy Moves Closer as Phase 3 Treatment Completes
08/17/2026 · 1:24 PM

Mesoblast’s Potential Blockbuster Back Pain Therapy Moves Closer as Phase 3 Treatment Completes

Mesoblast completes treatment of 350 patients in its pivotal Phase 3 trial of rexlemestrocel-L for chronic low back pain due to degenerative disc disease. Results expected mid-2027.

/ Subscriber only
/ Read more

Feed↓

Zscaler Reaffirms Guidance as Shares Climb on AI Security Demand
10/06/2026 · 5:53 PM

Zscaler Reaffirms Guidance as Shares Climb on AI Security Demand

Zscaler reaffirmed its first-quarter and fiscal 2027 guidance at its Investor Day in New York, citing steady demand for its Zero Trust platform as AI adoption expands.

/ Subscriber only
Black Hills Signs Deal to Power Google’s Planned Cheyenne Data Center Through 2048
10/06/2026 · 5:09 PM

Black Hills Signs Deal to Power Google’s Planned Cheyenne Data Center Through 2048

Black Hills will supply up to 590 MW and manage 2.1 GW for Google’s Wyoming data center. Google covers all costs; income starts in 2027.

/ Subscriber only
Caribou Biosciences Halts Two Off-the-Shelf CAR-T Programs and Weighs a Sale or Merger
10/06/2026 · 4:35 PM

Caribou Biosciences Halts Two Off-the-Shelf CAR-T Programs and Weighs a Sale or Merger

Caribou Biosciences will stop vispa-cel and CB-011 and review a sale or merger after funding pressure, with $113.8 million in cash.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI